Wordt geladen...
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
USP7 is a promising target for the development of cancer treatments because of its high expression and the critical functions of its substrates in carcinogenesis of several different carcinomas. Here, we demonstrated the effectiveness of targeting USP7 in advanced malignant cells showing high levels...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7697005/ https://ncbi.nlm.nih.gov/pubmed/33207738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21228629 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|